Works matching IS 08926638 AND DT 2022 AND VI 36 AND IP 1


Results: 61
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Issue Information.

    Published in:
    FASEB Journal, 2022, v. 36, n. 1, p. 1, doi. 10.1096/fsb2.22095
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood‐brain barrier: Therapeutic avenues.

    Published in:
    FASEB Journal, 2022, v. 36, n. 1, p. 1, doi. 10.1096/fj.202101297R
    By:
    • Sheikh, Madeeha H.;
    • Errede, Mariella;
    • d'Amati, Antonio;
    • Khan, Noorafza Q.;
    • Fanti, Silvia;
    • Loiola, Rodrigo A.;
    • McArthur, Simon;
    • Purvis, Gareth S. D.;
    • O'Riordan, Caroline E.;
    • Ferorelli, Davide;
    • Dell'Erba, Alessandro;
    • Kieswich, Julius;
    • Reutelingsperger, Chis;
    • Maiorano, Eugenio;
    • Yaqoob, Magdi;
    • Thiemermann, Christoph;
    • Baragetti, Andrea;
    • Catapano, Alberico Luigi;
    • Norata, Giuseppe Danilo;
    • Marelli‐Berg, Federica
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Molecular immuno‐imaging improves tumor detection in head and neck cancer.

    Published in:
    FASEB Journal, 2022, v. 36, n. 1, p. 1, doi. 10.1096/fj.202100864R
    By:
    • Li, Jing‐Hui;
    • Forghani, Reza;
    • Bure, Lionel;
    • Wojtkiewicz, Gregory R.;
    • Wu, Yue;
    • Iwamoto, Yoshiko;
    • Ali, Muhammad;
    • Li, Anning;
    • Wang, Cuihua;
    • Jalali Motlagh, Negin;
    • Papadakis, Andreas I.;
    • Pusztaszeri, Marc P.;
    • Spatz, Alan;
    • Curtin, Hugh;
    • Cheng, Ying‐Sheng;
    • Chen, John W.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Peptidyl‐prolyl cis‐trans isomerase NIMA‐interacting 1 directly binds and stabilizes Nrf2 in breast cancer.

    Published in:
    FASEB Journal, 2022, v. 36, n. 1, p. 1, doi. 10.1096/fj.202100776RR
    By:
    • Saeidi, Soma;
    • Kim, Su‐Jung;
    • Guillen‐Quispe, Yanymee N.;
    • Jagadeesh, Achanta Sri Venkata;
    • Han, Hyeong‐jun;
    • Kim, Seung Hyeon;
    • Zhong, Xiancai;
    • Piao, Juan‐Yu;
    • Kim, Seong‐Jin;
    • Jeong, Joon;
    • Shin, Yun Jin;
    • Cha, Yoon Jin;
    • Lee, Han‐Byoel;
    • Han, Wonshik;
    • Min, Sang‐Hyun;
    • Tian, Wang;
    • Kitamura, Hiroshi;
    • Surh, Young‐Joon
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.

    Published in:
    FASEB Journal, 2022, v. 36, n. 1, p. 1, doi. 10.1096/fj.202101194RRR
    By:
    • Fisher-Wellman, Kelsey H.;
    • Hagen, James T.;
    • Kassai, Miki;
    • Li-Pin Kao;
    • Nelson, Margaret A. M.;
    • McLaughlin, Kelsey L.;
    • Coalson, Hannah S.;
    • Fox, Todd E.;
    • Su-Fern Tan;
    • Feith, David J.;
    • Kester, Mark;
    • Loughran Jr, Thomas P.;
    • Claxton, David F.;
    • Cabot, Myles C.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50